The Nutshell

» policy, genetics & genomics and disease/medicine

Daily News Roundup

Most Recent

image: CDC Director Resigns Over Unresolved Conflicts of Interest

CDC Director Resigns Over Unresolved Conflicts of Interest

By Shawna Williams | January 31, 2018

Brenda Fitzgerald had drawn criticism for tobacco-related investments, among others.

0 Comments

News reports reveal that Volkswagen, Daimler, and BMW funded the organization that conducted the studies.

0 Comments

image: Monkeys Cloned by Dolly-the-Sheep Technology

Monkeys Cloned by Dolly-the-Sheep Technology

By Catherine Offord | January 25, 2018

The approach, which has never before been successfully attempted in primates, could lead to improved animal models for human biology and disease.

0 Comments

Both higher education and industry associations were advocating for a later implementation date for the Common Rule, which governs human studies.

0 Comments

image: EU Advisor Recommends Regulatory Exemption for Gene Editing

EU Advisor Recommends Regulatory Exemption for Gene Editing

By Catherine Offord | January 19, 2018

Crops produced using mutagenic technologies such as CRISPR should generally be exempt from regulatory laws governing GMOs, according to the published opinion.

0 Comments

Organophosphates jeopardize dozens of species, a federal review finds.

0 Comments

The BMJ inquiry finds that researchers presented only select results from animal experiments when applying for funding and approval for human trials.

0 Comments

The new policy affects academic and nonprofit grants and cooperative agreements exceeding $50,000. 

1 Comment

Researchers identify antibodies for two commonly used Cas9 proteins in human blood. Investors take notice.

0 Comments

image: Maternal Response to Zika Damages Mouse Fetuses

Maternal Response to Zika Damages Mouse Fetuses

By Catherine Offord | January 5, 2018

Signaling pathways triggered by the mother’s immune system may cause complications during fetal development.

1 Comment

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. North American Universities Increasingly Cancel Publisher Packages
  4. “Public” T-Cell Receptors From Resistant People Fend Off HIV